Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CBRS | NXPI |
|---|---|---|
| Price | $171.91 | $237.02 |
| Change today | ▼ 3.23% | ▼ 0.21% |
| Market cap | $40.84B | $59.77B |
| Return, 3 months | – | -15.1% |
| Return, year to date | – | +10.1% |
| Return, 1 year | – | +6.8% |
| P/E (TTM) | -80.5 | 20.2 |
| P/B | 4.5 | 5.2 |
| P/E percentile vs own 5y | 15th | 34th |
| Dividend yield | – | 1.71% |
| Revenue growth (YoY, latest qtr) | +74.3% | +19.5% |
| Net profit growth (YoY) | -245.6% | +71.1% |
| Gross margin | 34.8% | 56.0% |
| Operating margin | -81.2% | 27.3% |
| Net margin | -156.1% | 22.6% |
| Return on equity | -11.6% | 28.4% |
| Analyst target vs. price | +67.9% | +29.8% |
| Analyst buy share | 90% | 61% |
| RSI (14) | – | 51 |
| 30-day volatility | – | 33.4% |
| Max drawdown, 1 year | – | -34.0% |
| Trend read | – | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
